Nifty

:

17767.35

Sensex

:

60605.79

-86.70 (-0.49%)
-236.09 (-0.39%)

Login

Nifty
Sensex

:
:

17767.35
60605.79

-86.70 (-0.49%)
-236.09 (-0.39%)

Pfizer Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

61/99

BSE: 500680 | NSE: PFIZER

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,715.12
28.88
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

16,084.29
0.90%
6.07

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.55
5.81
6.66

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.33
10.80
7.86

PAT CAGR (%)

10 Years
5 Years
3 Years

1.99
11.21
6.36

P:E (Median)

8 Years
5 Years
3 Years

35.82
35.98
40.46

P:BV (Average)

8 Years
5 Years
3 Years

7.99
7.99
7.99

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.87
21.50
24.15

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 637.47 636.26 0.19% 592.90 749.17 -20.86% 549.66 534.76 2.79% 675.90 593.49 13.89%
Expenses 405.78 446.89 -9.20% 401.05 463.43 -13.46% 384.21 409.02 -6.07% 480.73 396.72 21.18%
EBITDA 231.69 189.37 22.35% 191.85 285.74 -32.86% 165.45 125.74 31.58% 195.17 196.77 -0.81%
EBIDTM 36.35% 29.76% 32.36% 38.14% 30.10% 23.51% 28.88% 33.15%
Other Income 24.24 15.03 61.28% 18.02 12.24 47.22% 17.12 37.20 -53.98% 18.26 14.57 25.33%
Interest 3.38 2.21 52.94% 3.64 2.25 61.78% 3.85 3.54 8.76% 2.18 3.85 -43.38%
Depreciation 26.25 27.23 -3.60% 26.51 27.00 -1.81% 33.61 27.31 23.07% 27.16 27.23 -0.26%
PBT 415.22 174.96 137.32% 43.39 268.73 -83.85% 145.11 132.09 9.86% 184.09 180.26 2.12%
Tax 104.15 32.01 225.37% 10.84 68.82 -84.25% 19.32 31.54 -38.74% 40.18 39.02 2.97%
PAT 311.07 142.95 117.61% 32.55 199.91 -83.72% 125.79 100.55 25.10% 143.91 141.24 1.89%
PATM 48.80% 22.47% 5.49% 26.68% 22.89% 18.80% 21.29% 23.80%
EPS 68.07 31.28 117.62% 7.12 43.74 -83.72% 27.53 22.00 25.14% 31.49 30.91 1.88%

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 2,455.93 2,610.99 2,238.55 2,151.65 2,081.50 1,968.51 1,966.26 2,012.34 1,853.32 1,111.81 1,048.84 Net Sales Growth -2.30% 16.64% 4.04% 3.37% 5.74% 0.11% -2.29% 8.58% 66.69% 6.00% Cost Of Goods Sold 882.54 875.65 734.29 741.69 678.48 677.55 711.67 698.85 649.77 305.51 270.02 Gross Profit 1,573.39 1,735.34 1,504.26 1,409.96 1,403.02 1,290.96 1,254.59 1,313.49 1,203.55 806.30 778.83 GP Margin 64.06% 66.46% 67.20% 65.53% 67.40% 65.58% 63.81% 65.27% 64.94% 72.52% 74.26% Total Expenditure 1,671.77 1,775.05 1,526.15 1,578.93 1,515.87 1,467.87 1,616.13 1,579.46 1,473.98 872.54 864.68 Power & Fuel Cost - 5.67 5.79 11.04 11.45 12.34 10.34 10.43 10.40 8.62 8.61 % Of Sales - 0.22% 0.26% 0.51% 0.55% 0.63% 0.53% 0.52% 0.56% 0.78% 0.82% Employee Cost - 403.67 361.06 364.51 323.84 314.29 303.89 277.34 236.36 191.77 211.12 % Of Sales - 15.46% 16.13% 16.94% 15.56% 15.97% 15.46% 13.78% 12.75% 17.25% 20.13% Manufacturing Exp. - 132.19 123.71 104.97 131.96 118.74 151.54 153.84 162.31 124.18 118.58 % Of Sales - 5.06% 5.53% 4.88% 6.34% 6.03% 7.71% 7.64% 8.76% 11.17% 11.31% General & Admin Exp. - 162.66 130.80 165.96 182.49 173.38 234.11 207.63 202.62 124.64 126.94 % Of Sales - 6.23% 5.84% 7.71% 8.77% 8.81% 11.91% 10.32% 10.93% 11.21% 12.10% Selling & Distn. Exp. - 148.11 137.87 153.70 152.83 143.35 152.82 168.00 156.82 87.83 100.10 % Of Sales - 5.67% 6.16% 7.14% 7.34% 7.28% 7.77% 8.35% 8.46% 7.90% 9.54% Miscellaneous Exp. - 47.10 32.63 37.06 34.82 28.22 51.76 63.38 55.71 29.98 100.10 % Of Sales - 1.80% 1.46% 1.72% 1.67% 1.43% 2.63% 3.15% 3.01% 2.70% 2.80% EBITDA 784.16 835.94 712.40 572.72 565.63 500.64 350.13 432.88 379.34 239.27 184.16 EBITDA Margin 31.93% 32.02% 31.82% 26.62% 27.17% 25.43% 17.81% 21.51% 20.47% 21.52% 17.56% Other Income 77.64 62.65 81.12 184.02 167.39 114.29 101.16 86.99 71.72 109.38 105.24 Interest 13.05 10.70 15.39 11.01 1.72 0.77 1.96 1.40 1.51 1.10 1.73 Depreciation 113.53 115.00 109.41 103.24 71.39 66.25 62.93 57.93 131.08 7.97 8.02 PBT 787.81 772.89 668.72 642.49 659.91 547.91 386.40 460.54 318.46 339.58 279.65 Tax 174.49 160.33 171.11 133.36 230.86 187.84 180.05 165.44 137.68 118.73 190.57 Tax Rate 22.15% 20.74% 25.59% 20.76% 34.98% 34.28% 34.84% 35.17% 66.36% 34.96% 27.47% PAT 613.32 612.56 497.61 509.13 429.05 360.07 336.78 304.98 69.82 220.86 503.20 PAT before Minority Interest 613.32 612.56 497.61 509.13 429.05 360.07 336.78 304.98 69.82 220.86 503.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 24.97% 23.46% 22.23% 23.66% 20.61% 18.29% 17.13% 15.16% 3.77% 19.86% 47.98% PAT Growth 4.90% 23.10% -2.26% 18.66% 19.16% 6.92% 10.43% 336.81% -68.39% -56.11% EPS 134.21 134.04 108.89 111.41 93.88 78.79 73.69 66.74 15.28 48.33 110.11

Description TTM Nov 08 Nov 07 Nov 06 Nov 05
Net Sales - 736.83 736.57 736.33 674.84 Net Sales Growth - 0.04% 0.03% 9.11% Cost Of Goods Sold - 195.94 190.88 186.99 189.67 Gross Profit - 540.89 545.69 549.34 485.17 GP Margin - 73.41% 74.09% 74.61% 71.89% Total Expenditure - 585.58 580.08 570.64 558.84 Power & Fuel Cost - 7.17 7.94 7.50 7.96 % Of Sales - 0.97% 1.08% 1.02% 1.18% Employee Cost - 98.43 98.71 100.37 98.57 % Of Sales - 13.36% 13.40% 13.63% 14.61% Manufacturing Exp. - 92.14 85.84 85.45 80.87 % Of Sales - 12.50% 11.65% 11.60% 11.98% General & Admin Exp. - 49.05 48.30 45.81 45.04 % Of Sales - 6.66% 6.56% 6.22% 6.67% Selling & Distn. Exp. - 99.87 106.89 103.95 96.59 % Of Sales - 13.55% 14.51% 14.12% 14.31% Miscellaneous Exp. - 42.98 41.51 40.57 40.15 % Of Sales - 5.83% 5.64% 5.51% 5.95% EBITDA - 151.25 156.49 165.69 116.00 EBITDA Margin - 20.53% 21.25% 22.50% 17.19% Other Income - 71.10 321.80 33.47 33.24 Interest - 0.00 0.02 0.07 0.16 Depreciation - 11.12 9.58 13.07 13.85 PBT - 211.22 468.69 186.01 135.23 Tax - 119.56 111.34 56.31 41.13 Tax Rate - 28.53% 24.67% 34.62% 36.77% PAT - 299.57 340.00 106.33 70.73 PAT before Minority Interest - 299.57 340.00 106.33 70.73 Minority Interest - 0.00 0.00 0.00 0.00 PAT Margin - 40.66% 46.16% 14.44% 10.48% PAT Growth - -11.89% 219.76% 50.33% EPS - 65.55 74.40 23.27 15.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 2,864.41 2,393.04 3,395.49 3,011.34 2,683.20 2,418.88 2,163.50 1,973.01 658.41 1,694.42 Share Capital 45.75 45.75 45.75 45.75 45.75 45.75 45.75 45.75 29.84 29.84 Total Reserves 2,818.66 2,347.29 3,349.74 2,965.59 2,637.45 2,373.13 2,117.75 1,927.26 628.57 1,664.58 Non-Current Liabilities 136.23 85.06 135.93 36.96 52.32 62.41 66.14 -34.97 -19.30 -25.71 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 2.50 2.50 0.00 0.00 Long Term Provisions 55.47 55.84 47.87 34.73 37.74 44.85 35.30 29.56 14.79 14.07 Current Liabilities 852.89 774.34 873.36 891.69 954.44 779.67 658.41 608.52 303.38 350.91 Trade Payables 263.94 283.74 426.78 435.92 495.63 388.00 337.92 334.20 159.93 150.59 Other Current Liabilities 338.44 361.47 340.37 294.19 302.29 241.36 181.52 80.59 54.68 39.56 Short Term Borrowings 2.50 2.50 2.50 2.50 2.50 2.50 0.00 0.00 0.00 0.00 Short Term Provisions 248.01 126.63 103.71 159.08 154.02 147.81 138.97 193.72 88.76 160.76 Total Liabilities 3,853.53 3,252.44 4,404.78 3,939.99 3,689.96 3,260.96 2,888.05 2,546.56 942.49 2,019.62 Net Block 840.96 864.74 941.91 853.86 916.60 867.08 924.86 944.34 20.02 25.57 Gross Block 1,345.28 1,278.52 1,277.00 1,100.27 1,094.86 983.27 980.63 1,288.60 114.83 117.27 Accumulated Depreciation 504.32 413.78 335.09 246.41 178.26 116.19 55.77 344.26 94.81 91.71 Non Current Assets 1,457.05 1,343.96 1,356.53 1,224.63 1,273.24 1,209.65 1,255.58 1,294.53 256.54 215.24 Capital Work in Progress 1.15 2.76 0.76 0.00 1.04 15.35 3.27 12.56 3.16 0.37 Non Current Investment 28.17 29.56 30.95 32.33 33.72 35.11 36.51 42.66 44.49 45.99 Long Term Loans & Adv. 429.91 291.62 255.26 225.11 236.25 226.29 225.71 294.97 188.87 143.31 Other Non Current Assets 156.86 155.28 127.65 113.33 85.63 65.82 65.23 0.00 0.00 0.00 Current Assets 2,396.48 1,908.48 3,048.25 2,715.36 2,416.72 2,051.31 1,632.47 1,252.02 685.95 1,804.39 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 448.90 435.05 430.59 386.66 297.06 321.90 360.68 387.90 151.50 165.15 Sundry Debtors 124.27 108.77 172.03 171.66 154.80 110.32 142.30 160.02 173.39 142.09 Cash & Bank 1,633.33 1,115.10 2,219.87 1,914.34 1,771.86 1,523.09 1,024.65 609.29 307.79 1,432.94 Other Current Assets 189.98 231.13 199.94 212.90 193.00 96.00 104.85 94.82 53.28 64.21 Short Term Loans & Adv. 30.10 18.43 25.82 29.80 45.96 52.48 57.20 80.52 47.17 43.23 Net Current Assets 1,543.59 1,134.14 2,174.89 1,823.67 1,462.28 1,271.64 974.06 643.51 382.58 1,453.47 Total Assets 3,853.53 3,252.44 4,404.78 3,939.99 3,689.96 3,260.96 2,888.05 2,546.55 942.49 2,019.63

Description Nov 08 Nov 07 Nov 06 Nov 05
Shareholder's Funds 901.09 649.72 439.76 375.95 Share Capital 29.84 29.84 29.84 29.84 Total Reserves 871.25 619.88 409.91 346.11 Non-Current Liabilities -22.67 -12.98 -14.36 -9.03 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 Current Liabilities 926.36 820.65 696.33 623.95 Trade Payables 108.18 92.43 137.62 120.16 Other Current Liabilities 14.50 14.17 8.14 16.26 Short Term Borrowings 0.00 0.00 0.00 0.00 Short Term Provisions 803.68 714.05 550.57 487.53 Total Liabilities 1,804.78 1,457.39 1,121.73 990.87 Net Block 50.76 60.16 69.96 75.56 Gross Block 139.90 141.61 168.14 170.15 Accumulated Depreciation 89.14 81.45 98.19 94.59 Non Current Assets 83.56 70.91 71.56 77.71 Capital Work in Progress 32.30 10.24 1.60 2.14 Non Current Investment 0.50 0.50 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 Current Assets 1,721.22 1,383.55 1,036.82 876.46 Current Investments 0.00 0.00 0.00 0.00 Inventories 124.99 95.85 99.31 90.71 Sundry Debtors 60.31 61.69 70.10 83.54 Cash & Bank 543.65 479.91 306.94 210.15 Other Current Assets 992.26 8.17 4.22 2.14 Short Term Loans & Adv. 977.77 737.92 556.25 489.92 Net Current Assets 794.86 562.90 340.50 252.52 Total Assets 1,804.78 1,457.39 1,121.72 990.87

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 667.08 427.33 323.18 97.81 331.80 328.82 345.48 113.47 132.45 -16.01 PBT 772.89 668.72 642.49 659.91 547.91 516.83 470.42 238.02 339.58 279.65 Adjustment 76.73 54.53 -53.56 -79.47 -32.98 -153.93 -19.53 60.89 -87.82 -84.49 Changes in Working Capital 43.38 -91.78 -52.46 -245.07 10.48 148.91 68.61 -40.42 4.62 -2.91 Cash after chg. in Working capital 893.00 631.47 536.47 335.37 525.41 511.81 519.51 258.48 256.39 192.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -225.92 -204.14 -213.29 -237.56 -193.61 -182.99 -174.03 -145.01 -123.94 -208.26 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -575.02 -468.84 1,530.32 35.12 -238.31 -249.64 -700.87 -88.77 102.66 625.87 Net Fixed Assets -65.15 -3.52 -177.49 -4.37 -97.28 -14.72 317.26 -1,183.17 -0.35 0.74 Net Investments 1.39 1.39 1.38 1.39 1.39 1.40 6.15 1.83 1.50 1.56 Others -511.26 -466.71 1,706.43 38.10 -142.42 -236.32 -1,024.28 1,092.57 101.51 623.57 Cash from Financing Activity -180.51 -1,571.07 -163.52 -109.85 -110.35 -82.59 -61.88 -1.38 -1,360.17 -43.20 Net Cash Inflow / Outflow -88.45 -1,612.58 1,689.98 23.08 -16.86 -3.41 -417.27 23.32 -1,125.06 566.66 Opening Cash & Equivalents 151.21 1,763.79 73.81 50.73 67.59 71.05 488.40 307.86 1,432.92 866.26 Closing Cash & Equivalent 62.76 151.21 1,763.79 73.81 50.73 67.59 71.05 488.40 307.86 1,432.92

Description Nov 08 Nov 07 Nov 06 Nov 05
Cash From Operating Activity 237.76 16.63 123.19 102.74 PBT 211.22 468.69 186.01 135.23 Adjustment -49.50 -298.40 -8.73 7.24 Changes in Working Capital -7.89 -33.39 11.64 -2.41 Cash after chg. in Working capital 153.83 136.91 188.92 140.06 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -126.90 -113.33 -65.74 -37.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -78.87 232.35 -47.99 -73.08 Net Fixed Assets -20.35 17.89 2.55 Net Investments 0.00 -0.50 0.00 Others -58.52 214.96 -50.54 Cash from Financing Activity -95.20 -75.90 -33.82 -46.02 Net Cash Inflow / Outflow 63.69 173.09 41.38 -16.36 Opening Cash & Equivalents 479.91 306.83 10.00 26.36 Closing Cash & Equivalent 543.61 479.91 51.38 10.00

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 626.10 523.07 742.18 658.22 586.49 528.72 472.92 431.28 220.64 567.81 ROA 17.24% 13.00% 12.20% 11.25% 10.36% 10.95% 11.22% 4.00% 14.91% 28.24% ROE 23.30% 17.19% 15.89% 15.07% 14.11% 14.70% 14.75% 5.31% 18.77% 33.56% ROCE 29.78% 23.62% 20.38% 23.22% 21.49% 22.62% 22.78% 15.87% 28.96% 46.38% Fixed Asset Turnover 1.99 1.75 1.81 1.90 1.91 2.08 1.85 2.75 10.04 9.32 Receivable days 16.29 22.89 29.15 28.62 24.43 22.58 26.35 31.59 49.42 47.27 Inventory Days 61.79 70.57 69.32 59.95 57.05 61.01 65.25 51.10 49.61 58.01 Payable days 114.15 176.59 102.95 115.62 121.93 93.70 92.76 62.95 78.13 72.79 Cash Conversion Cycle -36.07 -83.13 -4.48 -27.05 -40.45 -10.12 -1.16 19.73 20.89 32.50 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 73.23 44.45 59.36 384.67 712.57 264.69 337.93 138.46 310.56 401.51

Description Nov 08 Nov 07 Nov 06 Nov 05
Book Value (Rs.) 301.96 216.74 142.90 113.68 ROA 18.37% 26.37% 10.07% 9.39% ROE 38.71% 63.36% 27.78% 22.90% ROCE 54.15% 84.11% 42.50% 35.52% Fixed Asset Turnover 5.62 5.16 4.71 4.43 Receivable days 28.15 30.12 35.19 39.05 Inventory Days 50.96 44.60 43.53 41.49 Payable days 69.16 84.39 92.33 80.44 Cash Conversion Cycle 9.95 -9.68 -13.61 0.09 Total Debt/Equity 0.00 0.00 0.00 0.00 Interest Cover 0.00 0.00 2275.76 712.58

Top Investors:

life insurance corporation of india

aditya birla sun life trustee private limited a/c

nippon life india trustee ltd-a/c nippon india pharma fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Pfizer - Quarterly Results
11th Nov 2022, 16:15 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback